- Filed
- Apr 25, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Apr 12, 2022 | 165.19M sh |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $15.94K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $9.33K |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $179.38K |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $221.64K |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $736.65K |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $747.46K |
| Current Assets | Q1 2020 · Mar 31, 2020 | $88.4K |
| Current Assets | Q1 2020 · Dec 31, 2019 | $70.76K |
| Total Assets | Q1 2020 · Mar 31, 2020 | $88.4K |
| Total Assets | Q1 2020 · Dec 31, 2019 | $70.76K |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 165.19M sh |
| Operating Cash Flow restated | Q1 2020 · Mar 31, 2019 | −$12.21K |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | −$713.85K |
| Stockholders Equity | Q1 2020 · Dec 31, 2018 | −$670.89K |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | $0.00 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | $0.00 |
| Sga Expense restated | Q1 2020 · Mar 31, 2019 | $165.73K |
| Net Income | Q1 2020 · Mar 31, 2019 | −$42.96K |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | −$83.43K |
| Revenue | Q1 2020 · Mar 31, 2019 | $82.3K |